Q-Eng

　　　　　　　　　　　　　　　　　　　　　　　代表頁に戻る

従来、ワクチンは 研究・開発・治験・製造 に.10年以上かかかるものだった。
しかし 新型コロナワクチンは、わずか11か月で緊急使用が許可された。
実は何十年にもわたって開発されてきた医療技術.mRNAワクチンのおかげである。
この革新的なワクチンはどのように機能するのかを説明する。

難　５分　145wpm　　　　　　　　　　　　　　　　　　　　　　　2021年8月　　　　　　　　　　　　　　 　　　　　　　　　 　　　　

字幕 ： 開始後 で字幕On/Off､ で言語選択。文字の色やサイズﾞはｵﾌﾟｼｮﾝから｡
.　　　　 動画を見るとき、 でフルスクリーンに拡大すると見やすい。

★下記英文は ポップアップ辞書 が使えます｡
　　テキストはこちら⇒日英トランスクリプト （字幕はYouTubeの方が大きく見やすい）　　
　　　 　　　　　　 　　
In the 20th century, most vaccines took well over a decade to research, test, and produce. But the vaccines for COVID-19 cleared the threshold for emergency use in less than 11 months. The secret behind this speed is a medical technology that’s been developing for decades: the mRNA vaccine.

This new treatment uses our body’s existing cellular machinery to trigger an immune response, protecting us from viruses without ever experiencing an infection. And in the future, this approach might be able to treat new diseases almost as quickly as they emerge.

So how do these revolutionary vaccines work? The key ingredient is in the name. mRNA, or messenger ribonucleic acid（リボ核酸）, is a naturally occurring molecule that encodes the instructions for producing proteins. When our cells process mRNA, a part of the cell called the ribosome（リボソ－ム） translates and follows these instructions to build the encoded protein.
　mRNA. 　　： DNAから作られる「タンパク質を作るための設計図」
　リボソーム： mRNAからタンパク質を合成する翻訳反応を行う小器官

The mRNA in these vaccines works in exactly the same way, but scientists use the molecule to safely introduce our body to a virus. First, researchers encode trillions of mRNA molecules with the instructions for a specific viral protein. This part of the virus is harmless by itself, but helpful for training our body’s immune response.

Then, they inject those molecules into a nanoparticle roughly 1000 times smaller than the average cell. This nanoparticle is made of lipids（脂質）, the same type of fatty material that forms the membrane around our cells. But these lipids have been specially engineered to protect the mRNA on its journey through the body and assist its entry into the cell.

Lastly, the final ingredients are added: sugars and salt to help keep the nanoparticles intact until they reach their destination. Before use, the vaccine is kept at a temperature of -20 to -80 degrees Celsius to ensure none of the components break down.

Once injected, the nanoparticles disperse and encounter cells. The lipid coating on each nanoparticle fuses with the lipid membrane of a cell and releases the mRNA to do its work. At this point, we should note that while the vaccine is delivering viral genetic material into our cells, it’s impossible for this material to alter our DNA.

mRNA is a short-lived molecule that would need additional enzymes and chemical signals to even access our DNA, let alone change it. And none of these DNA altering components are present in mRNA vaccines.

Once inside the cell, the ribosome translates the mRNA’s instructions and begins assembling the viral protein. In COVID-19 vaccines, that protein is one of the spikes typically found on the virus’s surface. Without the rest of the virus this lone spike is not infectious, but it does trigger our immune response.

Activating the immune system（免疫システム） can be taxing on the body, resulting in brief fatigue, fever, and muscle soreness in some people. But this doesn’t mean the recipient is sick— it means the vaccine is working. The body is producing antibodies to fight that viral protein, that will then stick around to defend against future COVID-19 infections.

And since this particular protein is likely to be found in most COVID variants, these antibodies should reduce the threat of catching new strains. This approach offers significant advantages over previous vaccines. Traditional vaccines contain weakened versions of live viruses or amputated sections of a virus, both of which required time intensive research to prepare and unique chemical treatments to safely inject.

But mRNA vaccines don’t actually contain any viral particles, so they don’t have to be built from scratch to safely adjust each virus. In fact, every mRNA vaccine could have roughly the same list of ingredients.

Imagine a reliable, robustly tested vaccine that can treat any disease by swapping out a single component. To treat a new illness, researchers would identify the right viral protein, encode it into mRNA, and then swap that mRNA into the existing vaccine platform. This could make it possible to develop new vaccines in weeks, giving humanity a flexible new tool in the never-ending fight against disease.
--